Overview

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of paliperidone ER (in combination with or without benzodiazepines) in patients presenting with symptoms of agitation and/or aggression in the context of psychosis, and will generate data regarding both efficacy and safety in the acute setting.
Phase:
Phase 4
Details
Lead Sponsor:
Janssen Cilag N.V./S.A.
Treatments:
Paliperidone Palmitate